These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 39068230)
1. Analysis of the immune response using FTIR spectroscopy in mothers and their newborns with different vaccination schemes for COVID-19. Mata-Miranda MM; Martinez-Cuazitl A; Gutierrez-Cortes H; Cordero-Hernandez L; Guerrero-Ruiz M; Lopez-Reyes A; Rodriguez-Baez A; Vazquez-Zapien GJ Sci Rep; 2024 Jul; 14(1):17308. PubMed ID: 39068230 [TBL] [Abstract][Full Text] [Related]
2. Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis. Strengert M; Becker M; Ramos GM; Dulovic A; Gruber J; Juengling J; Lürken K; Beigel A; Wrenger E; Lonnemann G; Cossmann A; Stankov MV; Dopfer-Jablonka A; Kaiser PD; Traenkle B; Rothbauer U; Krause G; Schneiderhan-Marra N; Behrens GMN EBioMedicine; 2021 Aug; 70():103524. PubMed ID: 34391096 [TBL] [Abstract][Full Text] [Related]
4. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting. Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J Front Immunol; 2021; 12():802858. PubMed ID: 35003131 [TBL] [Abstract][Full Text] [Related]
5. Durability of humoral and cell-mediated immune response after SARS-CoV-2 mRNA vaccine administration. Mihaylova A; Lesichkova S; Baleva M; Nikolova-Vlahova M; Kundurzhiev T; Kolevski A; Naumova E J Med Virol; 2023 Jan; 95(1):e28360. PubMed ID: 36448089 [TBL] [Abstract][Full Text] [Related]
6. Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice. Slamanig S; González-Domínguez I; Chang LA; Lemus N; Lai TY; Martínez JL; Singh G; Dolange V; Abdeljawad A; Kowdle S; Noureddine M; Warang P; Singh G; Lee B; García-Sastre A; Krammer F; Schotsaert M; Palese P; Sun W EBioMedicine; 2024 Jul; 105():105185. PubMed ID: 38848648 [TBL] [Abstract][Full Text] [Related]
7. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days. Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R Front Immunol; 2021; 12():726960. PubMed ID: 34671348 [TBL] [Abstract][Full Text] [Related]
8. COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads. Golan Y; Prahl M; Cassidy AG; Gay C; Wu AHB; Jigmeddagva U; Lin CY; Gonzalez VJ; Basilio E; Chidboy MA; Warrier L; Buarpung S; Li L; Murtha AP; Asiodu IV; Ahituv N; Flaherman VJ; Gaw SL Front Immunol; 2021; 12():777103. PubMed ID: 34804068 [TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study. Stambouli N; Bahrini K; Romdhani C; Rebai A; Boughariou S; Zakraoui M; Arfaoui B; Seyli S; Boukhalfa Y; Battikh R; Moussa MB; Labbene I; Ferjani M; Gharssallah H J Immunol Methods; 2024 May; 528():113665. PubMed ID: 38490578 [TBL] [Abstract][Full Text] [Related]
10. Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination. Gorochov G; Ropers J; Launay O; Dorgham K; da Mata-Jardin O; Lebbah S; Durier C; Bauer R; Radenne A; Desaint C; Vieillard LV; Rekacewicz C; Lachatre M; Parfait B; Batteux F; Hupé P; Ninove L; Lefebvre M; Conrad A; Dussol B; Maakaroun-Vermesse Z; Melica G; Nicolas JF; Verdon R; Kiladjian JJ; Loubet P; Schmidt-Mutter C; Dualé C; Ansart S; Botelho-Nevers E; Lelièvre JD; de Lamballerie X; Kieny MP; Tartour E; Paul S JAMA Netw Open; 2024 Apr; 7(4):e248051. PubMed ID: 38652471 [TBL] [Abstract][Full Text] [Related]
11. Investigation of Anti-SARS-CoV-2-specific IgG Levels in Breast Milk after Vaccination or COVID-19 Infection. Temocin F; Çaycı YT; Seren C; Kuruoglu T; Atilla A; Birinci A; Tanyel E Am J Perinatol; 2024 May; 41(S 01):e3085-e3090. PubMed ID: 37846474 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 cellular and humoral responses in vaccine-naive individuals during the first two waves of COVID-19 infections in the southern region of The Netherlands: a cross-sectional population-based study. Hanssen DAT; Arts K; Nix WHV; Sweelssen NNB; Welbers TTJ; de Theije C; Wieten L; Pagen DME; Brinkhues S; Penders J; Dukers-Muijrers NHTM; Hoebe CJPA; Savelkoul PHM; van Loo IHM Microbiol Spectr; 2024 Jun; 12(6):e0012624. PubMed ID: 38686954 [TBL] [Abstract][Full Text] [Related]
13. Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study. Muñoz-Gómez MJ; Ryan P; Quero-Delgado M; Martin-Vicente M; Cuevas G; Valencia J; Jiménez E; Blanca-López N; Lara-Álvarez MÁ; Hernández-Rivas JÁ; Redondo G; Mas V; Sepúlveda-Crespo D; Vázquez M; Torres-Macho J; Martínez I; Resino S J Infect Public Health; 2024 Jul; 17(7):102473. PubMed ID: 38865774 [TBL] [Abstract][Full Text] [Related]
14. The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity. Tejedor Vaquero S; de Campos-Mata L; Ramada JM; Díaz P; Navarro-Barriuso J; Ribas-Llaurado C; Rodrigo Melero N; Carolis C; Cerutti A; Gimeno R; Magri G Front Immunol; 2021; 12():737083. PubMed ID: 34539673 [TBL] [Abstract][Full Text] [Related]
15. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. Beharier O; Plitman Mayo R; Raz T; Nahum Sacks K; Schreiber L; Suissa-Cohen Y; Chen R; Gomez-Tolub R; Hadar E; Gabbay-Benziv R; Jaffe Moshkovich Y; Biron-Shental T; Shechter-Maor G; Farladansky-Gershnabel S; Yitzhak Sela H; Benyamini-Raischer H; Sela ND; Goldman-Wohl D; Shulman Z; Many A; Barr H; Yagel S; Neeman M; Kovo M J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34014840 [TBL] [Abstract][Full Text] [Related]
16. PMMA dialyzers modulate both humoral and cell-mediate immune response to anti-COVID-19 vaccine (BNT162b2) in a cohort of chronic hemodialyzed patients. Castellano G; Netti GS; Cantaluppi V; Losappio V; Spadaccino F; Ranieri E; Marengo M; Borzumati M; Alfieri C; Stallone G Sci Rep; 2024 May; 14(1):12217. PubMed ID: 38806543 [TBL] [Abstract][Full Text] [Related]
17. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection. van der Ley PA; Zariri A; van Riet E; Oosterhoff D; Kruiswijk CP Front Immunol; 2021; 12():781280. PubMed ID: 34987509 [TBL] [Abstract][Full Text] [Related]
19. Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins. Afridonova ZE; Toptygina AP; Mikhaylov IS Biochemistry (Mosc); 2024 May; 89(5):872-882. PubMed ID: 38880648 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Anti-SARS-CoV-2-Specific Antibody Signatures in Maternal and Infant Blood after COVID-19 Infection versus COVID-19 Vaccination during Pregnancy. Sabharwal V; Taglauer E; Demos R; Snyder-Cappione J; Shaik-Dasthagirisaheb YB; Parker-Kelleher S; Hunnewell J; Boateng J; Clarke K; Yuen R; Barnett ED; Wachman EM; Yarrington CD Am J Perinatol; 2024 May; 41(S 01):e2970-e2977. PubMed ID: 37774748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]